BioLargo says subsidiary Clyra Medical's disinfectant spray Clyraguard now available on Amazon.com
The subsidiary also has a partnership with Powerplay Retail to roll-out Clyraguard to major retailers nationwide
Company
BioLargo Inc
OTCMKTS: BLGO
BioLargo Inc invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. The company accomplishes this by providing the capital, support, and expertise to expedite these disruptive technologies from "cradle" to "maturity". BioLargo monetizes through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. The company's patented technologies are all built to be best-in-class solutions to tough technical challenges, and they are backed up by world-class engineering and support services.
82 stories · page 4 of 5
BioLargo sees 3Q revenue rise by 60% with business development efforts paying off
For the period ended September 30, 2020, the Westminster, California-based company, reported revenue of $650,000
BioLargo Inc subsidiary Clyra Medical's COVID-19-inactivating spray Clyraguard now available to the public
Clyraguard is a hospital-grade, FDA-registered germicide that can be easily applied on the go, without having to remove a mask
BioLargo's CupriDyne-based disinfectant kills the coronavirus in 10 minutes, study says
The results were achieved in a third-party study of a modified CupriDyne formula at the Galveston National Laboratory at the University of Texas Medical Branch
BioLargo unveils first municipal wastewater trial of water treatment technology
The trial will take place at a treatment plant near Montréal in Québec and will be supervised by experts from the Centre des Technologies de L'Eau
Archive
NA Proactive news snapshot: NexTech AR, DGTL Holdings, Power Ore, Gevo UPDATE …
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
BioLargo sees demand increasing for its Clyraguard Personal Protection Spray that decontaminates personal protection equipment
The company expects substantial revenue increases from product sales of the spray in the third quarter of 2020
BioLargo says July sales doubled its monthly average thanks to new personal disinfectant
Its subsidiary Clyra Medical recently introduced Clyraguard Personal Protection Spray, an FDA-registered disinfectant for personal protective equipment
BioLargo says subsidiary manufactures first AEC prototype to eliminate PFAS contaminants from water
AEC is being tested and will be installed on-site for its first field pilot in the coming months
BioLargo subsidiary Clyra Medical names new CRO and business development head
Shawn Dougherty will serve as chief revenue officer with John Sirpilla taking over as chief business development officer
BioLargo says subsidiary's Clyraguard protective spray inactivates SARS-CoV-2 virus in lab tests
Clyraguard is a clear personal spray designed to help frontline healthcare workers prevent cross-contamination of their personal protective equipment
BioLargo Inc clocked record revenue in 2019 driven by new channel partnerships, commercial milestones
For the year ended December 31, 2019, the environmental engineering company posted a 37% rise in revenue to more than $1.8 million
BioLargo CEO Dennis P. Calvert says company still 'forging ahead' despite the coronavirus pandemic
He said BioLargo's major clients are municipalities, landfills and air force bases and the company continues to support them
BioLargo closes JV deal with South Korea’s BKT for CupriDyne Clean products
The newly formed venture will manufacture and support the distribution of odor and volatile organic compound control products
BioLargo unveils commercial design for Advanced Oxidation System for treating polluted water
It eliminates bacteria, viruses, and pathogenic organisms, and can reduce pharmaceuticals and antibiotics more effectively than standard systems used to treat wastewater
BioLargo Water launches crowdfunding campaign to get its wastewater treatment technology into poultry processing markets
The company's Advanced Oxidation System eliminates bacteria, viruses, and other pathogenic organisms from wastewater
BioLargo sets up JV with South Korea’s BKT and Tomorrow Water for CupriDyne Clean products
An annual dividend of $2 million will be paid to BioLargo to secure exclusive rights in perpetuity
BioLargo engineers top-notch, low-cost answer to PFAS water contamination problem
The firm’s Aqueous Electrostatic Concentrator device is effective in eliminating a toxic soup of PFAS chemicals from water
BioLargo’s subsidiary tackles PFAS toxic chemicals head-on with new treatment technology
BLEST’s Aqueous Electrostatic Concentrator was effective at eliminating a toxic soup of PFAS from water
BioLargo taps water industry veteran Tonya Chandler as director of strategic marketing and business development
She will focus on advancing sales and marketing BioLargo’s patented products and engineering services for water-related industries